Mevalonate Metabolism Regulates Basal Breast Cancer Stem Cells and Is a Potential Therapeutic Target
Christophe Ginestier(Inserm), Emmanuelle Charafe‐Jauffret(Inserm)
Cited by 145
Related Papers
CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts
|Journal of Clinical Investigation|2010|738